NACHC urged HHS Secretary Xavier Becerra to hold drug manufacturers accountable for restricting shipments of 340B drugs to contract pharmacies.
NACHC urged HHS Secretary Xavier Becerra to hold drug manufacturers accountable for restricting shipments of 340B drugs to contract pharmacies. …
340B contract pharmacy grew in affluent and White neighborhoods from 2011 to 2019 but declined in impoverished, Black, and Latino neighborhoods, a study published in JAMA Health Forum found. AHA strongly criticized the study.
340B contract pharmacy grew in affluent and White neighborhoods but declined in impoverished, Black, and Latino neighborhoods, a study [...] …
Yesterday's U.S. Supreme Court's opinion about deep cuts in 340B hospitals’ Medicare Part B drug reimbursement ended Phase 1 of the debate. Phase 2 gets underway next month in lower federal courts in Washington, D.C., and in the pages of the Federal register.
Yesterday's Supreme Court ruling about cuts in 340B hospitals’ Medicare Part B drug payments ended Phase 1 of the fight. [...] …
Clockwise from top left, Reps. Abigail D. Spanberger (D-Va.), Cindy Axne (D-Iowa), David McKinley (R-W.Va.), Doris Matsui (D-Calif.), John Katko (R-N.Y.), and Dusty Johnson (R-S.D.) are urging fellow House members to sign a letter urging HHS to begin 340B enforcement actions against drug companies.
Six U.S. House members (3 Ds and 3 Rs) are urging fellow House members to sign a letter urging HHS [...] …
NACHC's president and CEO told her counterpart at Merck the company's decision to impose conditions on 340B on health centers, but not on other grantee covered entities, "cannot be explained by logic, only greed.”
NACHC's president and CEO told her counterpart at Merck the company's decision to impose conditions on 340B pricing on health [...] …
The U.S. Supreme Court today struck down deep Medicare Part B drug reimbursement cuts for many 340B hospitals during 2018 and 2019. The decision does not affect continuation of the cuts in 2020 through this year, however.
The U.S. Supreme Court today struck down deep Medicare Part B drug reimbursement for many 340B hospitals during 2018 and [...] …
NACHC “would love to see” Congress pass legislation by the end of this year protecting health centers from drug manufacturers and PBMs' restrictions on 340B access, NACHC Senior Vice President Joe Dunn said during a news conference yesterday.
NACHC hopes Congress will pass legislation this year addressing PBMs and drug manufacturers' conditions on 340B utilization. …
Novo Nordisk announced refunds for 340B overcharges on six NDCs including one for Fiasp insulin.
Novo Nordisk announced refunds for 340B overcharges on six NDCs during Q3 2019. …
Arizona lawmakers have sent Gov. Doug Ducey (R) legislation prohibiting various forms of pharmacy benefit manager discrimination against 340B covered entities.
Arizona lawmakers have sent Gov. Doug Ducey (R) legislation prohibiting various forms of pharmacy benefit manager discrimination against 340B covered [...] …
HRSA is seeking comment on plans to revise online forms covered entities must fill when they enroll in the 340B program, recertify their eligibility annually, or update information in 340B OPAIS, the federal 340B program database.
HRSA is seeking comment on plans to revise online forms covered entities must fill when they enroll in the 340B [...] …
*Sign up for news summaries and alerts from 340B Report
Copyright © 2025 340B Report, LLC
Reproduction of material from any 340B Report page without written permission is strictly prohibited.
